Patent · US Active

Pyrimidine FGFR4 inhibitors

US10912774B2 · kind B2 · utility

0Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2019
Grant dateFeb 9, 2021
Priority date—
Expiry dateDec 17, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds of Formula I useful as FGFR4 inhibitors, as well as methods of use of the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.